Table 1.

Proportion of patients with “clinically abnormal” leukocyte counts^* after stroke.

Days after Stroke:	1 day				3 days				7 days				30 days				90 days
NIHSS:	≤5	6–16	≥17	P	≤5	6–16	≥17	P	≤5	6–16	≥17	P	≤5	6–16	≥17	P	≤5	6–16	≥17	P
WBCs>10,000	2/37	13/34	28/39	<0.001	3/39	7/36	17/39	0.001	2/33	7/33	17/35	<0.001	2/33	3/26	9/32	0.04	1/26	1/24	3/25	NS
	(5%)	(38%)	(72%)		(7%)	(19%)	(44%)		(6%)	(21%)	(49%)		(6%)	(12%)	(28%)		(4%)	(4%)	(12%)
PMNs>7,000	0/10	1/5	8/11	0.002	1/36	8/33	16/32	<0.001	1/30	4/29	13/30	<0.001	2/32	1/23	7/31	0.06	1/24	2/24	2/24	NS
	(0)	(20%)	(73%)		(3%)	(24%)	(50%)		(3%)	(14%)	(43%)		(6%)	(4%)	(23%)		(4%)	(8%)	(8%)
lymphocytes<1,000	0/10	1/5	3/11	NS	3/36	3/33	9/32	0.04	1/30	3/29	4/30	NS	3/31	2/23	3/31	NS	2/24	0/24	0/24	NS
	(0)	(20%)	(27%)		(8%)	(9%)	(28%)		(3%)	(10%)	(13%)		(10%)	(9%)	(10%)		(8%)	(0)	(0)
monocytes>800	3/10	2/5	6/11	NS	4/35	7/33	19/32	<0.001	5/30	8/29	17/30	0.003	3/32	3/23	8/30	NS	1/24	1/24	4/24	NS
	(30%)	(40%)	(54%)		(11%)	(21%)	(59%)		(17%)	(28%)	(57%)		(9%)	(13%)	(27%)		(4%)	(4%)	(17%)
eosinophils<50	1/10	1/5	8/11	0.008	2/36	4/33	14/31	<0.001	1/30	1/29	1/29	NS	1/32	0/23	0/30	NS	0/24	1/24	1/24	NS
	(10%)	(20%)	(73%)		(6%)	(12%)	(45%)		(3%)	(3%)	(3%)		(3%)	(0)	(0)		(0)	(4%)	(4%)

^*counts are presented as total number per μL, WBCs=white blood cells, PMNs=polymorphonuclear cells, NIHSS=National Institutes of Health Stroke Scale, NS=not significant (P>0.10)